Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Amplification of human papillomavirus early genes for detection of nine genotypes in Venezuelan women.

Michelli E, Téllez L, Mendoza JA, Noguera ME, Milano M, Vera R, Callejas D.

Invest Clin. 2013 Dec;54(4):392-405.

PMID:
24502181
2.

RNA (E6 and E7) assays versus DNA (E6 and E7) assays for risk evaluation for women infected with human papillomavirus.

Cattani P, Siddu A, D'Onghia S, Marchetti S, Santangelo R, Vellone VG, Zannoni GF, Fadda G.

J Clin Microbiol. 2009 Jul;47(7):2136-41. doi: 10.1128/JCM.01733-08. Epub 2009 Apr 29.

3.

[Study on the genotyping of human papillomavirus using a new DNA liquid chip in women of high-risk group of Shandong province].

Liu M, Wang CX, Deng XM, Wang LS, Zhang J, Li W, Zheng GX, Wang JF.

Zhonghua Liu Xing Bing Xue Za Zhi. 2007 May;28(5):487-90. Chinese.

PMID:
17877181
4.

Detection and genotyping of human papillomavirus DNA by SPF10 and MY09/11 primers in cervical cells taken from women attending a colposcopy clinic.

Perrons C, Kleter B, Jelley R, Jalal H, Quint W, Tedder R.

J Med Virol. 2002 Jun;67(2):246-52.

PMID:
11992586
5.

Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear.

Monsonego J, Pollini G, Evrard MJ, Sednaoui P, Monfort L, Quinzat D, Dachez R, Syrjänen K.

Int J STD AIDS. 2008 Jun;19(6):385-92. doi: 10.1258/ijsa.2007.007259.

PMID:
18595876
6.

Molecular epidemiology of human papillomavirus genotype in women with high-grade squamous intraepithelial lesion and cervical cancer: will a quadrivalent vaccine be necessary in Thailand?

Sukasem C, Pairoj W, Saekang N, Pombubpha H, Srichunrasami C, Pongtippan A, Junyangdikul P, Chantratita W.

J Med Virol. 2011 Jan;83(1):119-26. doi: 10.1002/jmv.21948.

PMID:
21108348
7.

Type-dependent E6/E7 mRNA expression of single and multiple high-risk human papillomavirus infections in cervical neoplasia.

Andersson E, Kärrberg C, Rådberg T, Blomqvist L, Zetterqvist BM, Ryd W, Lindh M, Horal P.

J Clin Virol. 2012 May;54(1):61-5. doi: 10.1016/j.jcv.2012.01.012. Epub 2012 Feb 10.

PMID:
22326759
8.

[Human papillomavirus typing in routine cervical smears. Results from a series of 3778 patients].

Levert M, Clavel C, Graesslin O, Masure M, Birembaut P, Quereux C, Gabriel R.

Gynecol Obstet Fertil. 2000 Oct;28(10):722-8. French.

PMID:
11244634
9.

Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.

Hudelist G, Manavi M, Pischinger KI, Watkins-Riedel T, Singer CF, Kubista E, Czerwenka KF.

Gynecol Oncol. 2004 Mar;92(3):873-80.

PMID:
14984955
10.

The evaluation of human papillomavirus genotyping in cervical liquid-based cytology specimens; using the Roche Linear Array HPV genotyping assay.

Jamison J, Wilson RT, Carson J.

Cytopathology. 2009 Aug;20(4):242-8. doi: 10.1111/j.1365-2303.2009.00643.x. Epub 2009 Mar 9.

PMID:
19291176
11.

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M.

J Natl Cancer Inst. 2005 Jul 20;97(14):1072-9.

PMID:
16030305
12.

Detection of human papillomavirus infection in women attending a colposcopy clinic.

Selva L, Gonzalez-Bosquet E, Rodriguez-Plata MT, Esteva C, Suñol M, Muñoz-Almagro C.

Diagn Microbiol Infect Dis. 2009 Aug;64(4):416-21. doi: 10.1016/j.diagmicrobio.2009.03.005. Epub 2009 Apr 18.

PMID:
19376675
13.

Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.

Monsonego J, Zerat L, Syrjänen K, Zerat JC, Smith JS, Halfon P.

Vaccine. 2012 Jul 27;30(35):5215-21. doi: 10.1016/j.vaccine.2012.06.013. Epub 2012 Jun 17.

PMID:
22713720
14.

Detection of persistent high risk human papillomavirus infections with hybrid capture II and SPF10/LiPA.

Perrons C, Jelley R, Kleter B, Quint W, Brink N.

J Clin Virol. 2005 Apr;32(4):278-85.

PMID:
15780805
15.

[Prevalence of genotype-specific HPV infection among women in France: implications for screening and vaccination].

Monsonego J, Zerat L, Syrjänen K, Zerat JC, Smith JS, Halfon P.

Gynecol Obstet Fertil. 2013 May;41(5):305-13. doi: 10.1016/j.gyobfe.2013.03.003. Epub 2013 May 3. French.

PMID:
23647817
16.

Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: the CLEOPATRE study.

Castellsagué X, Iftner T, Roura E, Vidart JA, Kjaer SK, Bosch FX, Muñoz N, Palacios S, San Martin Rodriguez M, Serradell L, Torcel-Pagnon L, Cortes J; CLEOPATRE Spain Study Group..

J Med Virol. 2012 Jun;84(6):947-56. doi: 10.1002/jmv.23282.

PMID:
22499018
17.

Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy.

Agarossi A, Ferrazzi E, Parazzini F, Perno CF, Ghisoni L.

J Med Virol. 2009 Mar;81(3):529-35. doi: 10.1002/jmv.21347.

PMID:
19152401
18.

Human papillomavirus genotype distribution in cervical samples collected in routine clinical practice at the Nantes University Hospital, France.

Vaucel E, Coste-Burel M, Laboisse C, Dahlab A, Lopes P.

Arch Gynecol Obstet. 2011 Oct;284(4):989-98. doi: 10.1007/s00404-010-1747-z. Epub 2010 Nov 25.

19.

Detection of 14 human papillomavirus genotypes in cervical samples in women from a central-southern area of Italy showing different Pap test results.

Zappacosta B, Romano L, Guerriero M, Graziano M, Vitrani A, De Ninno M, Carbone A.

New Microbiol. 2009 Oct;32(4):351-8.

20.

Development and evaluation of a highly sensitive human papillomavirus genotyping DNA chip.

Kim KH, Yoon MS, Na YJ, Park CS, Oh MR, Moon WC.

Gynecol Oncol. 2006 Jan;100(1):38-43. Epub 2005 Oct 10.

PMID:
16216319

Supplemental Content

Support Center